<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Strict//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-strict.dtd"><html xml:lang="en" lang="en" xmlns="http://www.w3.org/1999/xhtml"><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta name="ROBOTS" content="NOARCHIVE" /><meta name="googlebot" content="nosnippet" /><meta name="Document-Type" content="sub-topic" /><meta name="keywords" content="Chronic obstructive pulmonary disease; Obstructive pulmonary disease see Chronic obstructive pulmonary disease; COPD see Chronic obstructive pulmonary disease; Bronchitis: bronchodilators; Emphysema; Indacaterol; Roflumilast; Oxygen: alert card" /><meta name="IX" content="Chronic obstructive pulmonary disease; Bronchitis: bronchodilators; Emphysema; Indacaterol; Roflumilast; Oxygen: alert card" /><meta name="IXN" content="Obstructive pulmonary disease see Chronic obstructive pulmonary disease; COPD see Chronic obstructive pulmonary disease" /><title>Chronic obstructive pulmonary disease: British National Formulary</title><link type="text/css" rel="stylesheet" href="../../theme/theme.css" /><link type="text/css" rel="stylesheet" href="../../theme/print.css" media="print" /><link type="text/css" rel="stylesheet" href="59/style.css" /><link type="image/x-icon" rel="shortcut icon" href="favicon.ico" /><link rel="stylesheet" type="text/css" href="style/screen.css" media="screen" /><link rel="stylesheet" type="text/css" href="style/print.css" media="print" /><link rel="contents" type="text/html" href="index.htm" /><link rel="help" type="text/html" href="http://www.medicinescomplete.com/mc/help_page.htm" /><link rel="start" type="text/html" href="index.htm" title="British National Formulary" /><link rel="copyright" type="text/html" href="PHP0-publication-information.htm" title="Copyright information" /><link rel="bookmark" title="Skip Navigation" href="PHP1724-chronic-obstructive-pulmonary-disease.htm#pB" /><script type="text/javascript" src="https://ajax.googleapis.com/ajax/libs/jquery/1.7.0/jquery.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.tooltip.min.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.cookie.js"></script><script type="text/javascript" src="../../scripts/jquery/jquery.autosuggest.js"></script><script type="text/javascript" src="../../scripts/scripts.js"></script><style type="text/css">
  .contentsbox { position: fixed; z-index:1001;}
  .contentsbox_wrap {overflow:hidden;width:20px;height:130px; position:absolute;left:0;top:0;}
</style><!--[if lte IE 7]>
          <style type="text/css">
          .contentsbox {
          position: absolute;
          left: expression( ( 15 + ( ignoreMe2 = document.documentElement.scrollLeft ? document.documentElement.scrollLeft : document.body.scrollLeft ) ) + 'px' );
          top: expression( ( 250 + ( ignoreMe = document.documentElement.scrollTop ? document.documentElement.scrollTop : document.body.scrollTop) ) + 'px' );
          }
          .threecol_col3 {
          font-family: arial
          }
          .threecol_col3 a {
          font-family: verdana,helvetica,sans-serif
          }
          .threecol_col1 {
          font-family: arial
          }
          .threecol_col1 a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pE {
          font-family: arial
          }
          div#pE a {
          font-family: verdana,helvetica,sans-serif
          }
          div#pK {
          font-family: arial
          }
          div#pK a {
          font-family: verdana,helvetica,sans-serif
          }
          </style>
          <![endif]--></head><body><?highlighter off?><div id="pU"><a id="pD" accesskey="s" rel="bookmark" href="PHP1724-chronic-obstructive-pulmonary-disease.htm#pB" title="Skip Navigation">Skip Navigation</a><img src="../../images/mylogo.png" alt="BNF.org Free Access" id="pI" /><ul id="pZ"><li><a href="http://www.medicinescomplete.com/mc/account.htm">You are signed in as a member of <b>BNF.org Free Access</b></a></li><li> | <a href="http://www.medicinescomplete.com/mc/login.htm">Sign in different user</a></li><li> | <a href="http://www.medicinescomplete.com/mc/logout.htm">Sign out</a></li></ul><a href="http://www.medicinescomplete.com/mc/" title="Go to the MedicinesComplete home page"><img src="../../images/mc.png" alt="MedicinesComplete" /></a><ul id="pM"><li><a href="http://www.medicinescomplete.com/mc/" class="selected" accesskey="1" title="Home: access key 1"><strong><span>Home</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/"><strong><span>Welcome</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/feedback.htm?pub=bnf&amp;uri=PHP1724-chronic-obstructive-pulmonary-disease.htm" accesskey="9" title="Feedback: access key 9"><strong><span>Feedback</span></strong></a></li><li><a href="http://www.medicinescomplete.com/mc/help.htm" accesskey="6" title="Help button: access key 6"><strong><span>Help</span></strong></a></li></ul></div><div id="pA"><div id="pY">British National Formulary</div><div id="pG">Printed from: Joint Formulary Committee.  <i>British National Formulary</i>. [online] London: BMJ Group and Pharmaceutical Press.. &lt; http://www.medicinescomplete.com/ &gt; [Accessed on 06 Oct 2012 (GMT)].</div><div id="pQ"><form id="searchForm" method="get" action="http://www.medicinescomplete.com/mc/bnf/current/search.htm"><fieldset><legend>Details</legend><label for="q">Search for</label><div id="qd"><div><input accesskey="4" type="text" id="q" name="q" /><input class="button" id="searchButton" type="submit" value="Search" name="searchButton" title="Search full text" /></div></div></fieldset></form><script type="text/javascript">$(document).ready(function(){$("#q").autoSuggest('http://www.medicinescomplete.com/mc/bnf/current/search/suggest.xml', {control: "#searchButton"});});</script></div></div><div id="pH"><div id="pN"><div id="pT"><span class="cA"><a href="http://www.medicinescomplete.com/mc/">Home</a></span> &gt; <a href="index.htm">BNF September 2012</a> &gt; <a href="PHP1716-respiratory-system.htm">3 Respiratory system</a> &gt; <a href="PHP1717-bronchodilators.htm">3.1 Bronchodilators</a></div><div id="pP"><div class="threecol_col1">◄ <a accesskey="[" href="PHP1722-management-of-severe-acute-asthma.htm" title="Previous: Management of severe acute asthma">Previous page</a></div><div class="threecol_col2"> </div><div class="threecol_col3"><a accesskey="]" href="PHP1727-croup.htm" title="Next: Croup">Next page</a> ►</div></div></div></div><div id="p1"><div id="pB"><h1>Chronic obstructive pulmonary disease</h1><?highlighter on?><div id="pC" class="jN"><p>Smoking cessation (<a title="BNF:sub-section: Cigarette smoking" href="PHP3188-nicotine-dependence.htm">section 4.10.2</a>) reduces the progressive decline in lung function in chronic obstructive pulmonary disease (COPD, chronic bronchitis, or emphysema). Infection can complicate chronic obstructive pulmonary disease and may be prevented by vaccination (<a title="monograph-family: Pneumococcal vaccine" href="PHP8371-pneumococcal-vaccines.htm">pneumococcal vaccine</a> and <a title="monograph-family: Influenza vaccines" href="PHP8320-influenza-vaccines.htm">influenza vaccine</a>, section 14.4).</p><p>A trial of a high-dose inhaled corticosteroid <em>or</em> an oral corticosteroid is recommended for patients with moderate or severe airflow obstruction if the diagnosis is in doubt.</p><p>Symptoms of chronic obstructive pulmonary disease may be alleviated by an inhaled <strong>short-acting beta<sub>2</sub> agonist</strong> (<a title="sub-sub-section: Selective beta_2 agonists" href="PHP1734-selective-beta-2-agonists.htm">section 3.1.1.1</a>) or a <strong>short-acting antimuscarinic bronchodilator</strong> (<a title="sub-section: Antimuscarinic bronchodilators" href="PHP1787-antimuscarinic-bronchodilators.htm">section 3.1.2</a>) used as required.</p><p>When the airways obstruction is more severe, regular inhaled therapy should be used, see also <a title="BNF:target-block: COPD algorithm" href="PHP1724-chronic-obstructive-pulmonary-disease.htm#PHP1726">Use of Inhaled Therapies in Chronic Obstructive Pulmonary Disease</a>. It is important to check compliance and inhaler technique before initiating a new drug.</p><p>If the Forced Expiratory Volume in 1 second (FEV<sub>1</sub>), is 50% of predicted or more, <em>either</em> a long-acting antimuscarinic bronchodilator (<a title="sub-section: Antimuscarinic bronchodilators" href="PHP1787-antimuscarinic-bronchodilators.htm">section 3.1.2</a>) <em>or</em> a long-acting beta<sub>2</sub> agonist (<a title="BNF:target-block: Long-acting beta2 agonists" href="PHP1734-selective-beta-2-agonists.htm#PHP1736">section 3.1.1.1</a>) should be used. Short-acting antimuscarinic bronchodilators should be discontinued when a long-acting antimuscarinic bronchodilator is started. A long-acting beta<sub>2</sub> agonist with a corticosteroid (<a title="BNF:section: Corticosteroids" href="PHP1843-corticosteroids.htm">section 3.2</a>) in a combination inhaler can be used for patients who remain symptomatic despite regular treatment with a long-acting beta<sub>2</sub> agonist.</p><p>If FEV<sub>1</sub> is less than 50% of predicted, <em>either</em> a long-acting antimuscarinic bronchodilator <em>or</em> a long-acting beta<sub>2</sub> agonist with a corticosteroid in a combination inhaler should be used.</p><p>In any patient who remains breathless or continues to have exacerbations, triple therapy with a long-acting beta<sub>2</sub> agonist and a corticosteroid in a combination inhaler <em>plus</em> a long-acting antimuscarinic bronchodilator should be used.</p><p>If an inhaled corticosteroid is not appropriate, a long-acting antimuscarinic bronchodilator can be used with a long-acting beta<sub>2</sub> agonist.</p><p>If symptoms persist or if the patient is unable to use an inhaler, oral modified-release <strong>aminophylline</strong> or <strong>theophylline</strong> (<a title="sub-section: Theophylline" href="PHP1800-theophylline.htm">section 3.1.3</a>) can be used.</p><p><strong>Indacaterol</strong> (<a title="BNF:monograph: INDACATEROL" href="PHP1754-indacaterol.htm">section 3.1.1.1</a>) is a long-acting beta<sub>2</sub> agonist licensed for the maintenance treatment of chronic obstructive pulmonary disease.</p><p>In patients with severe chronic obstructive pulmonary disease associated with chronic bronchitis and a history of frequent exacerbations, <strong>roflumilast</strong> (<a title="BNF:monograph: ROFLUMILAST" href="PHP1892-roflumilast.htm">section 3.3.3</a>) is licensed as an adjunct to existing bronchodilator treatment.</p><p>A <strong>mucolytic</strong> drug (<a title="section: Mucolytics" href="PHP2018-mucolytics.htm">section 3.7</a>) may be considered for a patient with a chronic productive cough.</p><p>Long-term <strong>oxygen</strong> therapy (<a title="monograph-family: Long-term oxygen therapy" href="PHP2012-long-term-oxygen-therapy.htm">section 3.6</a>) prolongs survival in patients with severe chronic obstructive pulmonary disease and hypoxaemia.</p><p>During an exacerbation of chronic obstructive pulmonary disease, bronchodilator therapy can be administered through a nebuliser if necessary and oxygen given if appropriate. <strong>Aminophylline</strong> can be given intravenously if response to nebulised bronchodilators is poor. A short course of <strong>oral corticosteroid</strong> (<a title="sub-section: Glucocorticoid therapy" href="PHP4331-glucocorticoid-therapy.htm">section 6.3.2</a>), such as prednisolone 30 mg daily for 7–14 days, should be given if increased breathlessness interferes with daily activities. <strong>Antibacterial</strong> treatment (<a title="sub-topic: Respiratory system" href="PHP3261-respiratory-system.htm">Table 1, section 5.1</a>) is required if sputum becomes more purulent than usual, or if there are other signs of infection.</p><p>Patients who have had an episode of hypercapnic respiratory failure should be given a 24% or 28% Venturi mask and an <a title="BNF: target-block: Oxygen alert card" href="PHP1724-chronic-obstructive-pulmonary-disease.htm#PHP1725"><em>oxygen alert card</em></a> endorsed with the oxygen saturations required during previous exacerbations. Patients and their carers should be instructed to show the card to emergency healthcare providers in the event of an exacerbation, see also <a title="target-block: Low concentration oxygen therapy" href="PHP2009-oxygen.htm#PHP2010">section 3.6</a>.</p>  <p id="PHP1725"><img src="images/oxy_alert_card.png" alt="Oxygen alert card" /></p> <div class="cF"><p>Oxygen alert card based on British Thoracic Society guideline for emergency oxygen use in adult patients (October 2008); available at <a href="http://www.brit-thoracic.org.uk">www.brit-thoracic.org.uk</a></p></div>  <p id="PHP1726"><img alt="Chronic obstructive pulmonary disease" src="images/COPD_algorithm.png" /></p> </div><?highlighter off?><div id="pE">◄ <a accesskey="[" href="PHP1722-management-of-severe-acute-asthma.htm">Previous: Management of severe acute asthma</a> | <a class="top" href="PHP1724-chronic-obstructive-pulmonary-disease.htm#">Top</a> | <a accesskey="]" href="PHP1727-croup.htm">Next: Croup</a> ►</div></div></div><div id="pF"><div id="pL"><div id="footer"><div id="footerinner"><ul><li><a accesskey="0" href="accessibility.htm" title="Accessibility information: access key 0">Accessibility</a> | </li><li><a href="http://www.medicinescomplete.com/mc/marketing/current/contact.htm">Contact Us</a> | </li><li><a href="privacy.htm" title="Cookie and Privacy Policy">Cookie and Privacy Policy</a> | </li><li><a accesskey="3" href="http://www.medicinescomplete.com/mc/sitemap.htm" title="Site Map: access key 3">Site Map</a> | </li><li><a accesskey="8" href="terms.htm" title="Terms and Conditions: access key 8">Terms and Conditions</a></li></ul></div></div></div><div id="pX"><p><a href="PHP0-publication-information.htm" rel="copyright">Copyright © BMJ Group and Pharmaceutical Press 2012. All rights reserved. </a></p></div></div><script type="text/javascript">$(document).ready(function(){$.ga('UA-9959526-1');});</script></body></html>